Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by BuddingInvestoron Aug 03, 2018 6:09pm
97 Views
Post# 28413112

RE:RE:RE:News

RE:RE:RE:NewsSunny is the man! No doubt he's been a valuable contributor to this board for years. I wish we saw more of him on this board because he is very knowledgeable. I think/hope Vic has learned his lesson. He needs the sp to go up also to cash in on all the shares he's been stuffing his pockets with. Gaining the markets confidence back has been an uphill battle.
MickFlairDrip wrote:

Ladies and gentleman. Sunny is the most respected poster in the history of this board. I agree with all he’s said and then some. It’s easy to buy and sell these things for a loss because the insiders likely all found a way to pump and dump. This has been rinsed in repeated in all the shells he’s mentioned and then some. NUU was the last one, because the media picked up on it and the optics were simply catastrophic. The SP has reflected this 6+ months with no real end in sight. There is a huge elephant in the weedstock room as it pertains to NUU. What exactly did that 600 million bucks buy, other than more Aphria shares for all the insiders?  The pump house gang has been working overtime here. Doesn’t matter what month it is, thins “will get better” two months from now. At present it’s October, however, in May it was July. In November it will be January....so in and so forth. Be careful who you take advice from. This man is the only one to listen to. 



sunny3999 wrote: Sorry, i don't get it another 15 mn for what?  After giving Hiku/Tokio Smoke to Canopy where is the sense, as Lorne Gertner (Tokio Smoke) and Vic are advisors....

Its like shedding money with the watering can, without having a focus to buy, lead and grow companies. 

For me the strategy isn't clear at all -  just some examples:

- Canabo Medical Clinic bought and sold for a loss ?
- Kalytera Therapeutics bought sold with a loss ?
- Copperstate might be in Liberty or divested duw to US federal issues ?
- Nuuvera the biggest invest with unknown outcome or strategy ?
- buying Latam parts with an premium from Scythian and let them get Florida licence ?  
- Schottenstein-Aphria just one licence in Ohio 

Some invests made some money like Tetra BioPharma, Tokio Smoke/Hiku, LHS, but i dont get the real strategy for spending like watering can ?

Please enlight or give your view regards the situation ? (Thanks)   
   

raptor57 wrote:

 

Globe says Aphria commits $15M to Green Acre Capital

 

2018-08-03 08:22 ET - In the News

 

The Globe and Mail reports in its Friday edition that demand for private-equity investments in the cannabis sector remains high as Canada's legalization of recreational marijuana approaches. The Globe's Jeffrey Jones writes that Calgary's Green Acre Capital has received commitments of $35-million from the likes of Aphria, Brett Wilson and Saskatchewan cannabis funding firm York Plains Investment. Aphria is the largest contributor, committing $15-million. Its chief executive officer, Vic Neufeld, is on Green Acre's advisory board. Green Acre's first fund invested $25-million in 12 companies, with a focus on small firms offering ancillary products and services, such as cultivation technology, software and retail brands, notably Tokyo Smoke. "The cultivation side is a challenging, competitive market and what we observe in the legal U.S. states is that the pricing of cannabis tends to drop pretty sharply in those competitive markets," Green Acre managing director Tyler Stuart said. "So we decided to focus on all of the infrastructure around those growers. We found there's a lot of opportunity and the valuations are quite good." In addition, there is less competition for such investments, Mr. Stuart said.

© 2018 Canjex Publishing Ltd. All rights reserved.







Bullboard Posts